Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
20.0%
% of MEDX's 30 holdings also in XPH
14.6%
% of XPH's 41 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 5.1% | 3.7% | 3.7% |
|
BRISTOL-MYERS SQUIBB CO | 6.5% | 3.7% | 3.7% |
|
ELI LILLY & CO | 16.8% | 3.7% | 3.7% |
|
PFIZER INC | 4.0% | 3.6% | 3.6% |
|
MERCK & CO. INC. | 3.6% | 3.5% | 3.5% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to XPH
|
ELI LILLY & CO | 13.1% |
|
ABBVIE INC | 9.6% |
 |
NOVARTIS AG-ADR | 6.6% |
|
AMGEN INC | 6.3% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.6% |
|
ALNYLAM PHARMACEUTICALS INC | 4.7% |
 |
ALKERMES PLC | 4.7% |
|
REGENERON PHARMACEUTICALS | 2.8% |
|
BRISTOL-MYERS SQUIBB CO | 2.8% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.7% |
MEDX Underweight Relative to XPH
|
TARSUS PHARMACEUTICALS, INC. | -3.9% |
|
PERRIGO CO | -3.8% |
|
ZOETIS INC | -3.7% |
|
INTRA-CELLULAR THERAPIES INC | -3.7% |
|
ELANCO ANIMAL HEALTH, INC. | -3.7% |
|
CORCEPT THERAPEUTICS INC | -3.7% |
|
AXSOME THERAPEUTICS, INC. | -3.7% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.6% |
|
ORGANON & CO. | -3.6% |
|
ROYALTY PHARMA PLC CLASS A | -3.5% |